[PMID: 27581922] PubMed record related to this compound for laboratory literature review
Similar to our previous RNA-seq analysis, we demonstrate that treatment with GLP-1MK-801 significantly regulates around 150 times the number of hypothalamic transcripts relative to the weight-matched semaglutide-treated group, emphasizing a mode of action for GLP-1MK-801 that involves biological pathways independent of the GLP-1 receptor signalling pathway (Fig
Protective effect of UDCA against IL-11-induced cardiac fibrosis is mediated by TGR5 signalling
This approach, focused on individual therapies that provide both glycemic control and cardio-renal protection, has demonstrated significant potential in mitigating the severe outcomes associated with diabetic kidney disease (DKD)
Correcting deficiencies early protects immunity, bone strength, and brain function
European Review for Medical & Pharmacological Sciences, 27(20)